US Patent 7538110 Opioid antagonists
Patent 7538110 was granted and assigned to Adolor on May, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+188 characters)
Article
Patent abstract
Certain quinolizidine and octahydropyridopyrazine compounds, pharmaceutical compositions, and methods of their use, inter alia, as opioid receptor antagonists are disclosed.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07538110 Opioid antagonists US Patent 7538110 Opioid antagonists
Infobox
Patent Number
0753811000
Patent Number
753811000
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075381100
Date of Patent
May 26, 2009
0Patent Application Number
115528270
Date Filed
October 25, 2006
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075381100
Date of Patent
May 26, 2009
0Patent Application Number
115528270
Date Filed
October 25, 2006
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07538110 Opioid antagonists
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07538110
Date of patent
May 26, 2009
Patent application number
11552827
Date Filed
October 25, 2006
Patent primary examiner
Find more entities like US Patent 7538110 Opioid antagonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.